SucroMate Equine, a drug developed by Louisville biotech firm CreoSalus, has been approved to aid in broodmare ovulation. The drug could save horse breeders time and money by reducing the need for a second trip to the breeding shed.
SucroMate Equine, a drug developed by Louisville biotech firm CreoSalus, has been approved to aid in broodmare ovulation. The drug could save horse breeders time and money by reducing the need for a second trip to the breeding shed.
SucroMate Equine, a drug developed by Louisville biotech firm CreoSalus, has been approved to aid in broodmare ovulation. The drug could save horse breeders time and money by reducing the need for a second trip to the breeding shed.

Louisville biotech firm's drug could improve a broodmare's chance of pregnancy on the first date

February 14, 2011 12:00 AM